Delphi VC (@Delphi_VC) header
Delphi VC (@Delphi_VC) profile picture

Delphi VC

@Delphi_VC

Delphi VC invests in world-positive entrepreneurs with radical missions.

 San Francisco, Los Angeles
delphi.vc
Joined June 2018
  • Tweets12
  • Following63
  • Followers24
BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal This morning, Otsuka announced that its U.S. subsidiary has entered into an agreement to acquire methylone drug developer Transcend Therapeutics. Read more: psychedelicalpha.com/news/br…
Image from Psychedelic Alpha (@Psyched_Alpha)
2
9
5
29
29,631
Rose Delights feature from the Oct. 7th issue of the @NewYorker Full article at newyorker.com/culture/goings… Written by Rachel Syme Illustration by Subin Yang
Image from Rose Los Angeles (@rose_losangeles)
5
11
8,195
Our partnership with @APNLodge address a key question as @sama puts it “I don’t think anyone has yet figured out what the business of psychedelic medicine will look like..my hope is that Journey, with this new approach, will figure out something that actually works.”
The Washington Post (@washingtonpost) profile pictureThe Washington Post
@washingtonpost22 Apr 2023
Sam Altman and others in Silicon Valley bet drugs like MDMA will transform treatment for mental health wapo.st/3mW3Z5f
Executive behind ChatGPT pushes for a new revolution: Psychedelics

Executive behind ChatGPT pushes for a new revolution: Psychedelics

Sam Altman is behind a start-up that aims to tap into the promise that psychedelic drugs have shown for mental health and drug disorders, and make them widely available.

washingtonpost.com
1
2
4
839
TY @doubleblindmag for highlighting the @journeycolab Trust. Along with our patent pledge, it's an important initial step but more can always be done. I encourage experimentation and creativity with business structures & models - it is possible to create value in an inclusive way
DoubleBlind (@doubleblindmag) profile pictureDoubleBlind
@doubleblindmag21 Feb 2023
If you could re-design the world, what’s the first thing you would change? ✨ This burgeoning new psychedelic “industry” is projected to reach $10.75 billion in sales by 2027— but will it continue to fuel the same patterns of harm as other mega industries? doubleblindmag.com/elner-psy…

Psychedelic Pharma Has Arrived—But Will It Really Be Different from Big Pharma?

Psychedelic businesses have an opportunity to disrupt existing paradigms with regenerative economic practices. The question is: will they take it?

doubleblindmag.com
1
2
6
551
Very grateful that @journeycolab was able to have a voice in this piece: teapawt.net/Entrepreneur/status/15…
Entrepreneur (@Entrepreneur) profile pictureEntrepreneur
@Entrepreneur5 Jul 2022
Who gets to set the rules when a new industry emerges? entrepreneur.com/article/429…
The Burgeoning Psychedelics Industry Is Full of Money and Good Intentions. But Can It Avoid All Of...

The Burgeoning Psychedelics Industry Is Full of Money and Good Intentions. But Can It Avoid All Of...

There's a tipping point for every new industry. Psychedelics professionals are moving slowly, with caution, to be sure they tip in the right direction.

entrepreneur.com
2
3
Thank you to our investors and partners! Series A investors include @mbxcapital; @Delphi_VC; @sama and Apollo Projects (@maxaltman); Lionheart Ventures; @drewhouston (co-founder and CEO of Dropbox).
2
2
Honored to support the vision 🙏🏽@journeycolab secures $12M in Series A funding for its Phase 1 trial of mescaline for the treatment of Alcohol Use Disorder fiercebiotech.com/biotech/jo…
Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic

Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic

Psychedelics-focused biotech Journey Colab bagged $12 million to start its first human trial in 2022. | Psychedelics-focused biotech Journey Colab bagged $12 million to start its first human trial in...

fiercebiotech.com
1
Load more